ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2021
[Progress in the diagnosis and treatment of idiopathic non-cirrhotic portal hypertension].
Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 citations in OpenAlex.
- [Research progress on animal models relevant to porto-sinusoidal vascular disease].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025Review
- [Idiopathic portal hypertension: a case report].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024Article
- [Noninvasive assessment of the risk of esophageal variceal bleeding from noncirrhotic portal hypertension].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
Idiopathic non-cirrhotic portal hypertension is a rare group of clinical syndromes characterized by clinical manifestations of portal hypertension in the absence of histological manifestations of liver cirrhosis, and with the exclusion of known intrahepatic and extrahepatic causes of portal hypertension. Importantly, its etiology and pathogenesis are unclear, but it has been determined to be related to the development of intrahepatic vascular disease. It is currently believed that possible pathogenic mechanisms include immune disorders, chronic infections, drug-related poisoning or injury, microthrombosis, genetic abnormalities, etc. The most common clinical manifestations are esophagogastric varices and splenomegaly. Ascites and hepatic encephalopathy are the least common. Laboratory test demonstrates anemia, leukopenia, and thrombocytopenia due to hypersplenism, and normal or mild liver function abnormality. In addition, in the preclinical stage, despite the presence of abnormal portal vein during liver biopsy, no signs of portal hypertension can be detected in some patients. Therefore, the diagnosis is based on the diagnosis of exclusion and mandatory liver biopsy. The overall prognosis of idiopathic non-cirrhotic portal hypertension is better than that of patients with liver cirrhosis, but symptomatic treatment (controlling gastroesophageal varices bleeding and preventing thrombosis) is still the main treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.